Back to Screener

Healthcare

Cytek Biosciences, Inc.(CTKB)

Live Price

Offline

$4.47

+4.44% today

1Y Change

+25.88%

Window

Jun 30, 2025 โ†’ Jun 24, 2026

Market Cap
$610.00M
Revenue Growth
+0.5%
EPS Growth
-1030.4%
Dividend Yield
0.0%

Coverage: 248 bars ยท Jun 30, 2025 โ†’ Jun 24, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Cytek Biosciences, Inc. (CTKB) is a Healthcare stock with a market cap of $610.00M and listed on NASDAQ. The stock last traded around $4.47 and up 25.9% across the available one-year price window (Jun 30, 2025 โ†’ Jun 24, 2026). Baseline metrics include revenue growth of +0.5%, EPS growth of -1030.4%, a dividend yield of 0.0%. What stands out right now is revenue +0.5%, EPS -1030.4%, free cash flow -140.1% with operating margin -20.0% and ROIC -10.2%. Valuation is more restrained than many high-expectation growth names at price/sales 3.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines CTKB price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

CTKB vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

Relative Read

Mixed setup vs SPY

CTKB is 7.21 pts ahead over the shared 1Y window.

CTKB had 33.81 pts deeper max drawdown than SPY.

CTKB beat SPY in 1 of 2 calendar years shown and trailed in 1.

CTKB

+25.88%

Normalized return

SPY

+18.68%

S&P 500

Excess Return

+7.21 pts

Relative to SPY

CTKB Max Drawdown

-42.94%

Trailing 1Y

SPY Max Drawdown

-9.13%

Trailing 1Y

CTKBSPY

Calendar-Year Returns

Uses the longest available daily history for CTKB and SPY.

YearCTKBSPYExcessLeader
2026-13.01%+6.71%-19.72 ptsSPY
2025+48.53%+11.19%+37.34 ptsCTKB

Earnings Reports

๐Ÿ“… Last reportedMay 14, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
May 14, 26
โ€”
Est -0.07
โ€”
โ€”
Est 43950.3B
โ€”
May 14
โ€”
Feb 26, 26
โœ“
-0.01
Est -0.02
+50.0%
62141.0B
Est 57150.0B
+8.7%
Feb 26
โ€”
Nov 5, 25
โœ—
-0.01
Est 0.01
-200.0%
52293.0B
Est 58800.0B
-11.1%
Nov 5
โ€”
Aug 6, 25
โœ“
0.01
Est -0.02
+150.0%
45602.0B
Est 46349.0B
-1.6%
Aug 6
โ€”
May 8, 25
โœ—
-0.09
Est -0.04
-125.0%
41457.0B
Est 42663.0B
-2.8%
May 8
โ€”
Feb 27, 25
โœ“
0.07
Est 0.05
+40.0%
57476.0B
Est 59383.5B
-3.2%
Feb 27
โ€”
Nov 5, 24
โœ“
0.01
Est 0.00
+166.7%
51500.0B
Est 60885.9B
-15.4%
Nov 5
โ€”
Aug 6, 24
โœ—
-0.08
Est -0.03
-166.7%
46617.0B
Est 50700.0B
-8.1%
Aug 6
โ€”
May 8, 24
โ€”
-0.05
Est -0.05
0.0%
44860.0B
Est 43590.0B
+2.9%
May 8
โ€”
Mar 13, 24
โœ“
0.07
Est 0.03
+133.3%
58233.0B
Est 56580.0B
+2.9%
Mar 13
โ€”
Nov 7, 23
โœ“
0.01
Est -0.33
+103.0%
48000.0B
Est 55480.0B
-13.5%
Nov 7
โ€”
Aug 8, 23
โœ“
0.01
Est -0.01
+200.0%
49693.0B
Est 57640.0B
-13.8%
Aug 8
โ€”
May 9, 23
โœ—
-0.03
Est -0.01
-100.0%
37088.0B
Est 45720.0B
-18.9%
May 9
โ€”
Feb 28, 23
โœ“
0.07
Est 0.05
+40.0%
164036.0B
Est 47150.0B
+247.9%
Feb 28
โ€”
Nov 9, 22
โœ“
0.04
Est 0.02
+100.0%
40477.0B
Est 43288.0B
-6.5%
Nov 9
โ€”
Aug 10, 22
โœ“
0.03
Est 0.02
+80.0%
40159.0B
Est 39629.0B
+1.3%
Aug 10
โ€”
May 11, 22
โœ“
0.01
Est 0.00
+300.0%
35064.0B
Est 32508.3B
+7.9%
May 11
โ€”
Feb 23, 22
โœ“
0.05
Est 0.04
+20.0%
38894.0B
Est 36420.0B
+6.8%
Feb 23
โ€”
Nov 8, 21
โœ—
0.02
Est 0.02
-14.3%
34376.0B
Est 30408.0B
+13.1%
Nov 8
โ€”
Sep 3, 21
0.02
Est โ€”
โ€”
30408.0B
Est โ€”
โ€”
Sep 3
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the market calendar